This is a national telehealth platform focused on physician-guided, at-home allergy immunotherapy via a subscription model, helping patients access long-term, disease-modifying treatment without frequent in-office visits, while operating a fully compliant infrastructure licensed across all 50 states with integrated clinical, pharmacy, and technology workflows that support durable recurring revenue through multi-year treatment durations, strong retention, and efficient customer acquisition, alongside a rapidly scaling B2B channel that enables medical practices to offer allergy treatment without added operational complexity in a large, underserved chronic-care market. Key Highlights ✅ Modern at-home allergy immunotherapy delivered through a subscription model with physician oversight ✅ Fully compliant infrastructure licensed across all 50 states with integrated clinical, pharmacy, and technology workflows ✅ Durable recurring revenue supported by multi-year treatment durations, strong retention, and efficient customer acquisition ✅ Rapidly scaling B2B channel that enables medical practices to offer allergy treatment without added operational complexity ✅ Scalable, capital-efficient platform serving a large, underpenetrated segment of chronic care with long-term growth potential